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Background Bilirubin has been recognized as an anti-
oxidant. The purpose of this study was to examine
whether bilirubin would act as an antioxidant for
surgical stress in humans. Materials and Methods
Serum bilirubin and urinary bilirubin oxidative
metabolites (BOM) were measured in 96 patients
who underwent surgery. The antioxidant activity
of bilirubin was assessed using BOM measured
by enzyme-linked immunosorbent assay with an
anti-bilirubin monoclonal antibody. Results Serum
bilirubin levels increased after surgery in all 96
patients (p < 0.01), but did not correlate with opera-
tion time or blood loss (p 0.53 and p 0.28, respec-
tively). BOM increased only in patients with major
surgeries (p 0.048). Significant correlations between
BOM and operation time and blood loss were found
(p < 0.01). Conclusions Bilirubin appears to act as an
antioxidant for invasive surgery in humans. Urinary
BOM could be a reliable marker for the degree of
surgical stress.
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INTRODUCTION
Bilirubin is believed to be cytotoxic, and its
toxicity has been reported to be related to in-
jury to the mitochondrial membrane [1] or to
immune suppression [2,3]. Operative proce-
dures in patients with jaundice result in more
complications and increased mortality in com-
parison to those without jaundice. Postoperative
jaundice is often associated with sepsis or liver
failure [4]. Prolonged hyperbilirubinemia has
thus been considered to be a dangerous condi-
tion both before and after surgery. However, in
contrast to the toxic effect, Stocker et al., have
demonstrated a beneficial role for bilirubin in
that it can act as a powerful antioxidant in vitro
[5]. This observation was confirmed in rats
injected with endotoxin as a source of oxidative
stress in vivo [6]. Bilirubin oxidative metabolites
(BOM) have been identified in human urine. The
antioxidant activity of bilirubin can be assessed
by measuring these compounds with an enzyme-
linked immunosorbent assay (ELISA) [7].
Surgery is one of the oxidative stresses. Many
cytokines are released from macrophages, fibro-
blasts and endothelial cells, during surgery.
Neutrophils then increase in number and are
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activated to release granular enzymes as well
as reactive oxygen species [8,9]. Our current
working hypothesis is, therefore, that bilirubin
production is accelerated during surgery as a
spontaneous protection against oxidative stress.
In the present study, we explored the possibility
that bilirubin would act as an antioxidant in
humans during the perioperative period by
measuring urinary BOM as well as serum
bilirubin in relation to the severity of surgical
injury.
TABLE Diagnoses of 96 patients
Diagnosis Number of patients
Non-abdominal diseases 20
Breast tumor 7
Thyroid tumor 6
Inguinal hernia 3
Anal fistula 2
Myasthenia gravis 2
Abdominal diseases 76
Cholelithiasis 21
Gastric tumor 18
Colorectal tumor 8
Inflammatory intestinal disease 6
Pancreatic tumor 5
Other abdominal diseases 18
Total 96
MATERIALS AND METHODS
Patients
Ninty-six patients who underwent surgery from
September 1995 to January 1996 in the First
Department of Surgery, Kyushu University
Hospital, Fukuoka, Japan, were examined. Pa-
tients who had blood transfusions during the
perioperative period were excluded from the
study to avoid extra-loading of bilirubin from a
degradation of hemoglobin. Patients who had
preoperative liver or renal dysfunction or post-
operative complications were also excluded. The
mean age of the 41 male and 55 female patients
was 55.1 + 16.9 years; the range was 15 to 86
years. Table I lists the diagnoses and number of
patients studied. The diagnoses were made on
the basis of operative findings and pathological
examination. There was no statistical difference
in the value of bilirubin and BOM between
benign (n 56) and malignant (n 38) diseases.
The patients were divided into minor and
major surgery groups according to surgical
procedures (Tab. II). The patients were first
divided into two categories, abdominal and non-
abdominal (superficial) operations. However,
since the number of non-abdominal procedures
was small, the former group were further
divided into two subgroups, minor and major
laparotomies. The former included simple sur-
geries with short operation time, whereas the
TABLE II Classification of the patients by surgical pro-
cedures
Surgical procedure Number of patients
Minor operation 57
Non-laparotomy
Mastectomy 6
Thyroidectomy 6
Inguinal herniorrhaphy 3
Other non-laparotomy 5
Minor laparotomy
Cholecystectomy 22
Local resection of 4
gastrointestinal tract
Other minor laparotomy 11
Major operation 39
Gastrectomy 17
Colorectal resection 11
Distal pancreatectomy 3
Pancreaticoduodenectomy 2
Subtotal esophagectomy 1
Other major laparotomy 5
Total 96
latter complicated surgeries with long operation
time. The non-abdominal surgeries and the
minor laparotomies were combined and desig-
nated as the minor operation group and the
major laparotomies as the major surgery group.
Features of the patients in the two groups are
listed in Table III. The minor surgery patients
consisted of 18 males and 39 females ranging
from 15 to 86 years of age, with an average of
51.14-16.8 years. The major surgery patients
consisted of 23 males and 16 females ranging
from 20 to 80 years of age, with an average ofBILIRUBIN AS AN ANTI-OXIDANT FOR SURGICAL STRESS 243
TABLE III Comparison between the two surgical categories
Group
Sex
n Age (yr) (m/f)
Operation Blood loss
time (min) (ml)
Minor surgery 57
Major surgery 39
Total 96
n: number of the patients; m: male; f: female.
values are mean (s.d.); p < 0.01 vs minor surgery.
51.1 (16.8) 18/39 160 (91) 113 (130)
61.0 (15.5) 23/16" 272 (111)* 550 (464)*
55.1 (16.9) 41/55 205 (114) 291 (377)
61.0+15.5 years. Although age was not a
significant factor, there was a statistical differ-
ence in sex between the two groups (p <0.01).
Mean operation time for major surgery was
272 4-111 min and its mean blood loss volume
was 550 4- 464ml. Both data values are signifi-
cantly greater than those of the minor surgery
group with 160 4-91 min mean operation time
and 1134-130ml mean blood loss volume
(p < 0.01).
Sampling and ELISA Procedure
Urine samples of 10ml were collected from each
patient in the morning before surgery and on
days 1, 3, 5, 7,10 and 14 after surgery. They were
stored at -20C in the dark until use. The
concentration of BOM was measured using
ELISA with anti-bilirubin monoclonal antibody
as described previously by Shimizu [10] and
Izumi [11]. Briefly, 300 tl of urine and 300 tl of
saline were mixed well. Forty microlitres of this
mixture was incubated with 100 tl of antibody
solution for 20 min at 37C to reach equilibrium.
One hundred microlitres of the mixture was
transferred to immunoplates (Nunc, Roskilde,
Denmark) that had been coated with 100 tl/well
(10tg protein/well) of bilirubin-bovine serum
albumin (BSA) and then blocked with 100tl
of gelatin-fortified phosphate-buffered saline
(PBS). Free remaining antibody in the mixture
was allowed to bind to bilirubin-BSA on immu-
noplates. After a 30min incubation at 37C,
the immunoplates were washed 5 times, and
100 tl of the substrate solution was added. A
green color developed as a result of peroxidase
reaction. Thirty minutes later, absorbance was
measured at 415nm by ELISA analyzer BEP III
(Hechist, Tokyo, Japan). A calibration curve was
plotted as the ratio of B/Bo (B: mean absorbance
for each standard, B0: mean absorbance of the
control) against the bilirubin concentrations
expressed as log (i) (i: bilirubin concentration).
The concentrations of BOM were determined by
linear regression analysis.
Laboratory Examination
Serum total bilirubin concentration was ana-
lyzed by autoanalyzer (Hitachi 736-40 Auto-
matic Analyzer, Hitachi Co. Ltd, Tokyo, Japan)
during the same period described above.
Statistical Analysis
Data were analyzed using the StatView J-4.5
software program (Abacus Concepts, Berkeley,
California, USA). Results are expressed in terms
of mean. Wilcoxon signed-ranks test was used
to assess the differences between pre- and post-
operative means. Regression analysis and Spear-
man’s rank correlation coefficients were used
to determine the relationships between different
variables, and chi square test or the nonpara-
metric Mann-Whitney U test was used to assess
the difference between minor and major surgery
groups. P < 0.05 was considered significant.244 N. KOZAKI et al.
RESULTS
Changes in Serum Bilirubin and
Urinary BOM in all Patients
The mean 4- SEM concentrations of serum biliru-
bin and BOM in urine of all patients before and
after surgery are depicted in Figure 1. Before sur-
gery, serum bilirubin levelwas 0.71 4- 0.03 mg/dl.
It increased and reached a peak of 0.96 4-0.04
mg/dl on day 1 and decreased to the preopera-
tive level on day 5. On day 14, the level of
serum bilirubin was lower than the preoperative
level (p<0.01). The BOM level in urine was
0.75 4-0.05 tmol/g creatinine before surgery. It
increases slowly and reached a peak level of
0.97 4-0.10 tmol/g creatinine on day 7 and then
decreased gradually to the preoperative level on
day 14. Peak serum bilirubin level on day 1 was
significantly higher than the preoperative level
p < 0.01), but the increase ofBOM in urine on day
7 was not statistically significant p 0.11).
1o0
F: 0,4-
n()o 2
Postoperative day ---
bilirubin ---
BOM
FIGURE The level .of serum bilirubin and urinary BOM in
all patients. serum bilirubin; urinary BOM. Results are
mean + SEM. *p<0.01 versus day 0, indicating "before
surgery ".
Comparison between Minor and Major
Surgical Cases
To examine whether the levels of urinary BOM
would be influenced by the degree of surgical
stress and whether the increase of BOM would
be significant in any certain population, we
divided the whole group of patients into two
groups as mentioned above (Tabs. II and III).
The mean 4- SEM concentration ofBOM in urine
in each group was shown in Figure 2. While the
urinary BOM level was essentially constant in
the minor surgery group, it increased from
day 1 in the major surgery group and reached
a maximum level of 1.30 4- 0.20 tmol/g creati-
nine on day 7, returning to the preoperative
level on day 14. The increase on day 7 was
statistically significant when compared with the
preoperative value (p=0.048). In a comparison
between the two groups, the BOM concentration
was significantly higher in the major surgery
group on days 1,5 and 7 (p < 0.01). In contrast,
3 5 7 10 14
Postoperative day
Minor Surgery
Major Surgery
FIGURE 2 The level of urinary BOM in minor and major
surgery patients. minor surgery; major surgery. Results
are mean 4- SEM. *p < 0.05 versus day 0, indicating "before
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the levels of serum bilirubin showed no differ-
encebetween thetwo groups, and the increase ob-
served on day I for the total patients (Fig. 1) was
also demonstrated in each group.
Correlation of Serum Bilirubin and Urinary
BOM with Operation Time and Blood Loss
In Figure 3, the correlation between operation
time and the maximum level of serum bilirubin
after surgery is shown. There was no significant
correlation between these two factors (p=0.53).
However, the correlation between operation
time and the maximum level of BOM in urine
after surgery, shown in Figure 4, was signifi-
cant on a linear curve (y=0.004*10-4x+0.563,
r=0.42, p<0.01). According to the analysis of
blood loss, a significant correlation was similarly
shown with BOM only (y=0.001*10-4x+ 0.989,
r=0.43, p <0.01), and no linear correlation was
observed between serum bilirubin and blood
loss p 0.28).
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FIGURE 3 Correlation between operation time and maxi-
mum concentration of serum bilirubin. (y 2.48"10
-4x+ 0.92,
r 0.07, p 0.53).
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FIGURE 4 Correlation between operation time and maxi-
mum concentration of urinary BOM. (y=0.004*10-4x +0.56,
r 0.42, p < 0.01).
DISCUSSION
Bilirubin is synthesized from heme by a rate-
limiting enzyme, heme oxygenase. It has been
known as one of the "heat shock proteins,"
being dramatically induced in response to a
variety of stress-associated agents including
ultraviolet A (320- 380 nm) irradiation, hydro-
gen peroxide (H202), and heavy metals as well
as tumor promoters [12-14]. Endotoxin, tumor
necrosis factor (TNF), interleukin 1 (IL-1) and
interleukin 6 (IL-6) have also been recognized as
stimulants [15-18]. It is of interest that all of
these stimulating reagents lead to the produc-
tion of reactive oxygen species [13], which
means the induction of heme oxygenase is a
general response to a variety of oxidant stresses
in many mammalian cells [19].
The fact that bilirubin, the end-product of this
activated enzyme, is proved to be a powerful
antioxidant seems reasonable with respect to the
fact that bilirubin is formed actively in stress
conditions in order to neutralize the generated
oxidants. In order to evaluate the antioxidant246 N. KOZAKI et al.
activity of bilirubin in vivo, Yamaguchi et al.
established an ELISA system to measure BOM
[7]. They first detected substances other than
bilirubin that interacted with anti-bilirubin
monoclonal antibody. They purified these from
human urine and determined the structures of
two compounds [7]. In contrast to bilirubin,
which is a tetrapyrrole, BOM consist of three
pyrrole rings and are thought to be produced
when bilirubin molecules are destroyed oxida-
tively at the site of the pyrrole rings A or D [7].
These oxidative metabolites of bilirubin were
subsequently proved to increase markedly by
an endotoxin injection in the urine of rats in
accordance with the elevation of liver heme
oxygenase [6]. These results confirmed that
bilirubin was oxidized in rats, acting as a
physiological antioxidant and that the measure-
ment of BOM in urine reflected the oxidant
activity of bilirubin.
Our data described herein is summarized as
follows: (1) Serum bilirubin significantly in-
creased shortly after surgery regardless of the
severity of surgery. (2) The concentration of
BOM in urine elevated only after major surgery
and the BOM levels in the major surgery group
were higher than those in the minor surgery
group. (3) The degree of increase in urinary
BOM, but not the level of serum bilirubin, was
statistically correlated with the length of opera-
tion time and the volume of blood loss.
The elevation of serum bilirubin reached a
maximum level as early as the next day after
surgery. The mRNA of heme oxygenase has
been reported to be induced in the early phase of
reaction against stress, being highest around 14
hours in fibroblasts after irradiation [20], and
around 5 hours in rats after endotoxin injection
[6]. The activity of the enzyme produced in rats
was also demonstrated to be high as early as 6
hours after endotoxin injection [6]. The elevation
of bilirubin was detected in the similar range of
time. This confirms the hypothesis that bilirubin
is actively synthesized by the enzyme. The
measurements of mRNA or enzyme activity
were not carried out in the present study since
this would require samples to be collected from
the liver or spleen of the patients repeatedly
after surgery. Animal models are needed to
obtain further direct confirmation of our results.
In addition, findings that the increase of bilir-
ubin occurred both in minor and major sur-
geries, and that there was a lack of correlation
between the maximal level of serum bilirubin
and the operation time or blood loss, suggested
that bilirubin would be produced readily by
minimal operative procedures. This phenomen-
on seems similar to the reaction of heme oxy-
genase mRNA in that levels close to maximum
mRNA levels are reached at the low end of the
dose range in all patients with radiation tohuman
skin fibroblasts [19]. Induction of heme oxy-
genase to produce bilirubin seems to have a low
threshold related to oxidative stress.
The reason why bilirubin returned to a level
lower than the preoperative level 14 days after
surgery is unclear (Fig. 1). One possibility is an
overconsumption of bilirubin. It is reported that
cigarette smoke, which is also known to be an
oxidant, significantly lowers the plasma level
of bilirubin in humans [21]. If the generated
oxygen radicals exceed the production of bilir-
ubin, the level of serum bilirubin decreases to a
lower concentration. The contribution of differ-
ence in sex to our conclusion is uncertain.
The increase of BOM in urine after surgery
confirmed that bilirubin acted as antioxidant
during surgery in humans, similarly to that
shown in vitro [5] or in vivo using rats treated
with endotoxin [6]. The correlation of operation
time and blood loss with BOM but not with
bilirubin suggested that the amount of bilirubin
to be used as antioxidant could be determined
by the amount of generated reactive oxygens,
whereas bilirubin itself was quickly induced
by the smallest surgical stress as a spontaneous
physiological response to potential oxidants.
Because the increased release of superoxide anion
from monocytes or neutrophils was reported
in more invasive surgeries [22], BOM could beBILIRUBIN AS AN ANTI-OXIDANT FOR SURGICAL STRESS 247
produced in accordance with the severity of
surgical injury. When loaded with more severe
surgical stress, more bilirubin was consumed to
scavenge more oxidants. As a result, more BOM
was excreted into urine after long and major
surgeries. Urinary BOM, but not serum bilirubin,
could be a good marker for evaluating the
severity of surgical stress.
Bilirubin has been regarded as a cytotoxic,
lipid-soluble waste. As discussed above, how-
ever, it plays an important role in patients with
surgical stress. When incorporated into the
model of a cell membrane, it has been reported
to eliminate peroxyl radicals for lipid peroxida-
tion to an extent beyond a-tocopherol, which
has been regarded as the best antioxidant of
lipid peroxidation [5]. Moreover, albumin-
bound bilirubin, shown to have antioxidant
properties, could appear in inflammatory exu-
date across the vascular wall into the sites of
increased production of oxygen radicals, since
the binding of bilirubin to albumin distributes
the pigment throughout the entire circulation
and extravascular space [23]. There are lots of
oxidant scavengers other than bilirubin, but
their interactions are not clearly understood.
Further studies are necessary to elucidate the
mechanism of induction of bilirubin and the
metabolism of BOM, and to investigate the other
disorders related to the antioxidant activity of
bilirubin.
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A number of products, including cytokines
(TNFc and IL-6 for example), are known to
induce the production of these products. Para-
meters that can directly or indirectly reflect these
oxidative events, have important bearings to
assess the degree of tissue damage and injuries.
The study by Kozaki and colleagues demon-
strates that bilirubin oxidative metabolites,
correlates with the type of surgical procedure,
operating time and blood loss. These observa-
tions, together with those previously reported
that the bilirubin oxidative metabolites are
indicators of oxidative damage in animal stu-
dies, suggest a possible beneficial nature to
monitor these products in clinical practice.
Furthermore, these oxidative products can be
measured in urine with a well-established
technique, making the test an attractive and
non-invasive option. Studies on other type of
diseases, such as sepsis may be important to
establish this context.
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